DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Feltes TF, Cabalka AK, Meissner HC. et al.
Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.
J Pediatr 2003;
143: 532-540
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.